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Título: Funcionamiento biopsicosocial entre pacientes cirróticos en distin-
tas etapas del proceso de trasplante y su comparación con trasplantados 
hepáticos. 
Resumen: Antecedentes: Si bien la evaluación de la calidad de vida en fases 
previas y posteriores al trasplante es un objetivo científico de actualidad; és-
ta aún no ha sido abordada a lo largo de todo el proceso de trasplante. Ob-
jetivos: 1) Comparar la salud mental y calidad de vida en las tres siguientes 
fases del proceso de trasplante: en el estudio previo a la lista de espera, en 
lista de espera y en fase post-trasplante; 2) analizar la correlación entre estas 
variables afectivas y de calidad de vida y las puntuaciones en Model for 
End-Stage Liver Disease (MELD). Métodos: Se seleccionaron dos grupos de 
pacientes hepáticos: 51 pacientes cirróticos evaluados en dos etapas (en el 
estudio previo a la lista de espera y en lista de espera), y 51 pacientes con 
trasplante hepático procedente de un donante cadáver; ambos grupos igua-
lados en género y edad mediante apareo. Se emplearon como instrumentos 
el HADS y el Cuestionario de Salud SF-36. Resultados: Los pacientes en estu-
dio pre-lista de espera percibieron su estatus global de salud mucho peor 
que los pacientes trasplantados. Los pacientes en lista de espera presenta-
ron mucha mayor ansiedad, más limitaciones funcionales por problemas fí-
sicos, peor funcionamiento físico, y percibieron su estatus global de salud 
mucho peor que los pacientes trasplantados. Correlaciones estadísticamen-
te significativas fueron únicamente observadas en los pacientes en lista de 
espera entre MELD y las subescalas de Ansiedad y Funcionamiento Social. 
Conclusiones: Los pacientes en lista de espera presentaron el peor estatus de 
bienestar biopsicosocial; por el contrario, los trasplantados hepáticos goza-
ron del mejor nivel en estas dimensiones. 
Palabras clave: Sintomatología ansioso-depresiva; calidad de vida; estudio 
pre-lista de espera; fase lista de espera; trasplante hepático. 
  Abstract: Background: Although assessment of pre- and post-transplant 
quality of life is a current scientific target; it has not yet been carried out 
throughout the entire transplant process. Aims: 1) To analyze differences 
in mental health and quality of life at pre-waiting-list-study, waiting-list, 
and post-transplant phases; 2) to analyze correlation between these quality-
of-life and affective variables and Model for End-Stage Liver Disease 
(MELD) scores. Methods: Two liver patient groups were recruited: 51 cir-
rhotic patients, who were assessed at two different stages (at pre-waiting-
list-study and waiting-list phases), and 51 cadaveric liver transplant recipi-
ents; groups were homogeneous in gender and age variables by matching. 
Anxiety-depressive symptomatology and quality of life were assessed by 
HADS and SF-36 Health Survey, respectively. Results: Pre-waiting-list-study 
patients self-perceived their global health status much worse than trans-
plant recipients. Waiting-list patients displayed much higher anxiety, more 
role limitations due to physical problems, worse physical functioning, as 
well as perceiving their global health status much worse than transplant re-
cipients. Statistically significant correlations were only found in waiting-list 
patients between MELD-Anxiety and MELD-Social Functioning sub-
scales. Conclusions: Waiting-list patients displayed the worst biopsychosocial 
well-being status; liver transplant recipients enjoyed the best status instead. 
Key words: Anxiety-depressive symptomatology; quality of life; pre-
waiting-list study; waiting-list phase; liver transplant. 
 
Introduction 
 
Currently, liver transplant is the treatment of choice for pa-
tients with severe hepatopathy with poor short-term progno-
sis. For the past decades, this intervention has shown rele-
vant advances, with very satisfactory results in terms of sur-
vival and quality of life (Forsberg, Bäckman, & Svensson, 
2002; Karam et al., 2003; Ripoll & Bañares, 2008). However, 
most investigations of quality of life among transplant recip-
ients conclude that these patients’ quality of life does not 
reach the levels of the general population (Sumskiene, 
Sumskas, Petrauskas, & Kupcinskas, 2006; Taylor, Franck, 
Gibson, & Dhawan, 2005), not even 15 years after the surgi-
cal intervention (Kousoulas et al., 2008). 
Therefore, this is a process that involves several compli-
cations since the moment the patients undergo a medical 
study in order to consider the possibility of their inclusion 
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on the waiting list, followed by their admission on the wait-
ing list, until they are finally transplanted. 
However, although the survival of severe hepatopathic 
patients has been studied during several phases of this hospi-
tal process, the functional state of the patients during all 
three stages has received much less attention (Gutteling, de 
Man, Busschbach, & Darlington, 2007; Perkins, 2009), and 
the results about whether or not quality of life improves af-
ter transplant are controversial (Braun et al., 2009; Karam et 
al., 2003; Ratcliffe et al., 2002; Sainz-Barriga et al., 2005; 
Telles-Correia, Barbosa, Mega, Mateus, & Monteiro, 2009). 
Consequently, in this study, we aimed to offer more empiri-
cal evidence about the quality of life and mental health of 
these patients, as well as to analyze the relationship of these 
variables with liver disease severity during this entire hospital 
process. Most studies regarding biopsychosocial outcomes 
during the transplant process do not usually include patients 
who are hospitalized in order to undergo a pre-waiting-list 
study because of their severe liver disease. Therefore, it is re-
ally important to identify the psychological complications 
suffered by these patients during all stages of this medical 
process and the differences among them. 
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During the pre-waiting-list study, the patients and their 
relatives both suffer the medical assessment with a mixture 
of conflictive feelings, distress, and ambivalence. This state 
may encompass the hope of attaining a healthy future and a 
normal life, combined with fear of the risks of surgical inter-
vention, particularly graft rejection. Most patients express 
willingness to carry on with the assessment, but they also 
display high anxiety levels due to possibility of being includ-
ed on the waiting list (Rainer, Thompson, & Lambros, 2010). 
When the need for a transplant has already been decided 
-because other therapeutic procedures have been dismissed- 
waiting-list patients continue to experience ambivalent feel-
ings. On the one hand, transplant intervention represents the 
possibility of recovering health and quality of life; however, 
it is also a source of fear and uncertainty in view of possible 
medical complications after transplant. Overall, this stage has 
been identified as the most distressful period of the entire 
transplant process, where anxiety is the most frequent reac-
tion, which could negatively affect the post-operative phase 
(Jiménez-Torres, Martínez, Miró, & Sánchez, 2012; Rainer et 
al., 2010; Scott, 2004). 
On the other hand, although research concludes that 
transplant improves physical and social functioning, as well 
as promoting a return to daily activities, there are some con-
troversial results regarding mental health (Rainer et al., 2010). 
In this sense, some of the following psychological difficulties 
are displayed after transplant: mood disorders, anxiety disor-
ders, sexual dysfunctions, fantasies about the donor, and 
body image dissatisfaction (Dew et al., 1994, 2005; Pérez-
San-Gregorio, Martín-Rodríguez, & Galán-Rodríguez, 2005). 
Nevertheless, many investigations show that liver transplant 
recipients enjoy significantly better quality of life than cir-
rhotic patients, particularly than patients with advanced 
hepatopathy (O’Carroll, Turner, Flatley, McGregor, & Hayes, 
2008; Pantiga et al., 2005; Pérez-San-Gregorio et al., 2012). 
Cirrhotic patients’ quality of life is impaired due to the char-
acteristic symptoms of liver disease, especially if it is decom-
pensated. Subsequently, this aspect varies after transplant 
because most patients report significant improvement.  
The Model for End-Stage Liver Disease (MELD) has 
been established as a measure of hepathic disease severity, 
replacing the Child-Turcotte-Pugh (CTP) for liver allocation, 
because the MELD scores predict short-term survival better 
than the CTP scores (Wiesner et al., 2003). However, in view 
of the fact that current liver transplantation research does 
not only focus on survival but also on quality of life, there is 
increasing scientific interest in analyzing the relationship be-
tween the MELD and quality-of-life dimensions. To date, 
the results about this relationship are controversial, ranging 
from an absence of correlation (Ortega et al., 2009; Saab et 
al., 2005) to negative correlations (Kanwal, Hays, Kilbourne, 
Dulai, & Gralnek, 2004; Rodrigue, Lisson, Wiak, Nelson, & 
Reed, 2006), or even positive correlations (the higher the 
MELD scores, the better quality of life), but only in cases of 
very severe hepatopathy (Castaldo, Feurer, Russell, & Pin-
son, 2009). 
Therefore, in view of the relevance of this topic and tak-
ing various phases of the transplant process into account, in 
the current investigation, we aimed to study the following 
specific goals. Firstly, to compare quality of life and anxiety-
depressive symptomatology between: 1) cirrhotic patients at 
two phases of transplant process, that is, pre-waiting-list-
study and waiting-list stages; 2) cirrhotic patients from the 
pre-waiting-list study and liver transplant recipients; and 3) 
cirrhotic patients on the waiting list and liver transplant re-
cipients. Lastly, we aimed to analyze the correlations be-
tween these patients’ quality of life, affective variables, and 
MELD scores. 
 
Method 
 
Participants 
 
To carry out this investigation, we formed two liver pa-
tient groups: 51 cirrhotic patients and 51 liver transplant re-
cipients. The former patients were assessed at two time 
points: a) firstly, when they were admitted to the Digestive 
Diseases Unit for a medical study in order to determine their 
inclusion on the waiting list (pre-waiting-list study); b) sec-
ondly, when they had been admitted on the waiting list for 
subsequent liver transplant. This cirrhotic patient group was 
made up of 44 men and 7 women, mean age 55.16 years (SD 
= 8.09 years). Regarding etiology of liver cirrhosis, it was 
frequently alcoholic cirrhosis (n = 24) and hepatitis C virus 
(HCV) (n = 17), followed by others (n = 7) and hepatitis B 
virus (HBV) (n = 3). Their mean MELD score during the 
pre-waiting-list study was 15.81 (SD = 4.13) and, at the wait-
ing-list stage, 16.88 (SD = 3.96).  
The transplant recipient group was made up of 44 men 
and 7 women, mean age 54.98 years (SD = 7.74 years). They 
had all received a first liver transplant five years ago, on av-
erage, proceeding from a deceased donor. With regard to the 
clinical variables, the etiology of the disease leading to trans-
plant was mainly alcoholic cirrhosis (n = 20), followed by 
hepatocarcinoma (n = 11), HCV (n = 10), HBV (n = 5), and 
others (n = 5). Their mean MELD score was 17.17 (SD = 
4.01). 
 
Instruments 
 
Psychosocial survey  
 
This was created by the authors for the current investiga-
tion and included several sociodemographic and clinical vari-
ables: gender, age, etiology of cirrhosis, and MELD scores. 
 
Hospital Anxiety and Depression Scale (HADS) (Zigmond & 
Snaith, 1983) 
 
This instrument has 14 items, 7 of depression and 7 of 
anxiety, on which patients rate how they felt during the past 
week, selecting one out of four responses. The test provides 
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two scores, one for each subscale; in both cases, the scores 
are classified as:  normal (0-7 points), doubtful (8-10 points), 
and clinical problem ( 11 points). In Spanish studies, 
Cronbach´s alpha values range between .80 and .90. We used 
the Spanish version developed by Caro and Ibáñez (Caro & 
Ibañez, 1992). 
 
SF-36 Health Survey (Alonso, Prieto, & Antó, 1995) 
 
This is made up of 36 items, each one with various re-
sponse alternatives that provide a health status profile. The 
test explores eight dimensions: physical functioning, role 
limitations due to physical problems, bodily pain, general 
health perceptions, vitality, social functioning, role limita-
tions due to emotional problems, and general mental health. 
In each dimension, a score ranging from 0 (worse health sta-
tus) to 100 (better health status) is obtained. Alonso et al. 
(1995) studied the psychometric properties of this test in 
Spanish population and found that internal consistency 
(Cronbach's alpha) of the diverse dimensions ranged be-
tween .45 and .94, with a mean value of .78, and always 
above the value of .70, except for the dimension Social 
Functioning, which did not exceed .45. For test-retest relia-
bility, the correlation coefficients ranged between .51 and 
.85. 
 
Procedure  
 
In the two groups (cirrhotic patients and liver transplant 
recipients), the following inclusion criteria were taken into 
account: being over 18 years of age, having a reading/writing 
level that allowed them to complete the diverse scales em-
ployed, not being currently in psychiatric or psychological 
treatment, not presenting any severe or incapacitating pa-
thology at the moment of assessment, and giving their writ-
ten informed consent to participate in the investigation. 
Aside from these general requirements, there were other 
specific inclusion criteria depending on the patient group. 
Regarding the cirrhotic patients: either being admitted to the 
Digestive Diseases Unit for a medical study to determine 
their inclusion on the waiting list; or else the Transplant 
Commission had already decided their inclusion on the wait-
ing list for subsequent liver transplant, taking the following 
criteria into account: suffering from a hepatic pathology; 
other therapeutic interventions were not possible or had 
failed; and survival about one year later was less than survival 
that would be achieved by means of liver transplant. With 
regard to transplant recipients, the specific inclusion criterion 
was having received a first liver transplant proceeding from a 
deceased donor; retransplant recipients and possible recipi-
ents of a combined liver-kidney transplant were excluded. 
Both groups of patients were selected from the Universi-
ty Hospital Virgen del Rocío of Seville, taking into account 
that the Ethics and Health Research Commission had previ-
ously approved the adequacy and implementation of this in-
vestigation. Once we had received approval, the medical data 
of the patients were obtained through the Hepatic-Biliary-
Pancreatic Surgery and Liver Transplant Unit and from the 
Digestive Diseases Unit. 
To select the group of cirrhotic patients, we started with 
all the patients who, during a 2-year interval (2009 and 2010), 
had been scheduled for admittance in the Digestive Diseases 
Unit in order to undergo a pre-liver transplant study due to 
the advanced state of their hepathic pathology. During this 
time interval, 83 patients were admitted; we excluded 8 of 
them because they did not meet the inclusion criteria: 3 
could not read or write, 4 did not wish to participate, and 1 
was under study for a liver-kidney transplant. Therefore, we 
assessed 75 patients in the pre-waiting-list study, taking into 
account that 24 cirrhotic patients were not included on the 
waiting list because of not meeting above-mentioned specific 
inclusion criteria. Finally, these 51 cirrhotic patients were as-
sessed twice during the medical protocol for a liver trans-
plant. 
To select the group of transplant recipients, we started 
with a clinical population made up of all the patients in Se-
ville who had received a liver transplant from a deceased 
person during the 1990-2007 interval. During this time in-
terval, 662 liver transplants were carried out in adults, of 
whom 236 died. Of the 426 living transplant recipients, 28 
could not be located, and 230 did not meet the inclusion cri-
teria: 44 could not read or write, 36 were in psychiatric 
and/or psychological treatment, 140 did not wish to partici-
pate, and 10 had been retransplanted. We finally assessed 
168 patients.  
As we aimed to have two homogeneous patient groups 
(cirrhotic patients and liver transplant recipients), we selected 
51 liver transplant recipients from the 168 assessed previous-
ly. To carry out this goal, we formed the groups by matching 
gender and age. When there were several patients meeting 
the same conditions, random selection was used. 
 
Statistical Analysis 
 
Data were analyzed with the SPSS 19.0 statistical pack-
age. To compare continuous variables between pre-waiting-
list and waiting-list groups, we used Student’s t-test for 
paired samples (first goal). To compare pre-waiting-list and 
waiting-list groups with transplant recipients, we used Stu-
dent’s t-test for unpaired samples (second and third goal). To 
analyze the relationship between MELD scores and quality 
of life and affective variables, we computed Pearson’s corre-
lations for these three intergroup comparisons (fourth goal). 
When homocedasticity was not achieved, we took Welch’s t 
into account instead of Student’s t-tests. We used Cohen’s d 
as effect size indexes (Cohen, 1992), computing them from 
the means and standard deviations, instead of t-tests in order 
to avoid the overestimating associated with paired t-test val-
ues (Dunlap, Cortina, Vaslow, & Burke, 1996). Likewise, we 
performed item analysis by means of t-tests for those items 
of the subscales whose previous pairwise comparisons had 
obtained large effect sizes. 
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Results 
 
Firstly, we aimed to ensure that post-transplant time -
number of months passed from transplantation to assess-
ment- (M = 56.71 months, SD = 40.04) did not influence 
any quality of life and affective variables. Therefore, we 
computed Pearson’s correlations and no statistically signifi-
cant correlations were found in most dimensions, excepting 
in bodily pain (r = .286, p = .42), although reaching a small-
to-moderate effect size. Overall, since simple linear regres-
sion is based on Pearson’s correlations, we can conclude that 
post-transplantation time did not predict changes in quality 
of life and affective variables.  
 
Pre-transplant phase: psychological differences be-
tween cirrhotic patients at the pre-waiting-list study 
and on the waiting list. 
 
Regarding variables that assess affective status (anxiety 
and depression by means of HADS), no statistically signifi-
cant differences were found in any subscale: Anxiety (p = 
.344) and Depression (p = .305) (Table 1). 
With regard to quality of life, statistically significant dif-
ferences were only found in the Physical-Role (p = .017) and 
General Health (p = .015) subscales (Table 1). In both di-
mensions, patients displayed better scores when they were at 
the pre-waiting-list study than on the waiting-list phase for 
transplant (Figure 1).  
After computing effect sizes, null and small effect sizes 
were obtained in all variables.  
 
Table 1. Comparisons in Mental Health (HADS) and Quality of Life (SF-36). 
 
Psychological 
variables 
 
Intergroup comparisons 
Pre-waiting and waiting 
list patients 
(n = 51) 
 
Cohen’s 
d 
Pre-waiting list and 
transplant recipients 
(n = 51) 
 
Cohen’s 
d 
Waiting List and 
transplant recipients 
(n = 51) 
 
Cohen’s 
d 
HADS1:       
- Anxiety t(50) = -.955 
p = .344 
-0.10 – 
 
t(91.27) = -3.251 
p = .002** 
0.64 M 
 
t(95.10) = -4.008 
p = .000** 
0.80 L 
 
- Depression t(50) = -1.037 
p = .305 
-0.13 – 
 
t(100) = -2.894 
p = .005** 
0.57 M 
 
t(90.68) = -3.601 
p = .001** 
0.71 M 
 
SF-362:       
- Bodily pain t(50) = -.811 
p = .421 
-0.13 – 
 
t(100) = 1.200 
p = .233 
-0.24 S 
 
t(100) = 0.495 
p = .622 
-0.10 – 
 
- Physical-role t(50) = 2.467 
p = .017** 
0.30 S 
 
t(100) = 2.921 
p = .004** 
-0.58 M 
 
t(100) = 4.631 
p = .000** 
-0.92 L 
 
- Mental health t(50) = 1.602 
p = .116 
0.20 S 
 
t(100) = 1.898 
p = .061 
-0.38 S 
 
t(100) = 2.854 
p = .005** 
-0.57 M 
 
- General health t(50) = 2.512 
p = .015** 
0.27 S 
 
t(100) = 6.157 
p = .000** 
-1.22 L 
 
t(100) = 7.474 
p = .000** 
-1.48 L 
 
- Vitality t(50) = 1.258 
p = .214 
0.17 – 
 
t(100) = 2.785 
p = .006** 
-0.55 M 
 
t(100) = 3.678 
p = .000** 
-0.73 M 
 
- Social functioning t(50) = 1.238 
p = .221 
0.19 – 
 
t(100) = 1.652 
p = .102 
-0.33 S 
 
t(96.57) = 2.589 
p = .011* 
-0.51 M 
 
- Emocional-role t(50) = 1.861 
p = .069 
0.24 S 
 
t(100) = 0.760 
p = .449 
-0.15 – 
 
t(94.22) = 2.007 
p = .048* 
-0.40 S 
 
- Physical functioning t(50) = 1.506 
p = .138 
0.19 – 
 
t(100) = 3.733 
p = .000** 
-0.74 M 
 
t(100) = 4.733 
p = .000** 
-0.94 L 
 
1 The higher score, the worse mental health.  2The lower score, the worse quality of life. * p < 0.05, ** p < 0.01 
Effect sizes, Cohen’s d: –, null; S, small; M, medium; L, large. 
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Figure 1. SF-36 comparisons between cirrhotic patients and liver transplant recipients. 
 
Pre- and post-transplant phase: psychological differ-
ences between cirrhotic patients at the pre-waiting-
list study and transplant recipients.  
 
Regarding affective status variables, statistically signifi-
cant differences were found both in the Anxiety (p = .002) 
and Depression (p ≤ .005) subscales and medium effect sizes 
were reached. As observed in Table 1 and Figure 2, pre-
waiting-list patients reached higher scores than transplant re-
cipients in both variables. 
 
 
Figure 2. HADS comparisons between cirrhotic patients and liver transplant recipients. 
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With regard to quality of life, statistically significant dif-
ferences were found in four dimensions: Physical-Role (p = 
.004, medium effect size), Vitality (p = .006, medium effect 
size), Physical Functioning (p ≤ .000, medium effect size), 
and General Health (p ≤ .000). Particularly, transplant pa-
tients reached higher scores in all these subscales in compari-
son to cirrhotic patients at the pre-waiting-list study; that is, 
the transplant recipients enjoyed better quality of life (Table 
1 and Figure 1). Only one subscale achieved a large effect 
size, General Health, where three items presented the high-
est group differences (Table 2).  
 
Table 2. Comparisons between liver transplant recipients and patients on pre-waiting list regarding SF-36 dimensions with a large (L) effect size. Items Ana-
lysis. 
SF-36 ITEMS 
Liver transplant  
recipients 
(n = 51) 
M (SD) 
Pre-waiting list 
patients 
(n = 51) 
M (SD) 
t-test 
(p) 
 
Cohen’s 
d 
General health     
- In general, would you say your health is… 1 
57.84 
(26.21) 
20.10  
(20.01) 
t(100) = 8.173 
(.000**) 
1.619 L 
How true or false is each of the following statements for you:     
- I am as healthy as anybody I know 2 
60.78 
(32.88) 
31.86  
(25.04) 
t(93.39) = 4.997 
(.000**) 
0.990 L 
- My health is excellent 2 
63.24 
(32.15) 
27.45  
(27.50) 
t(100) = 6.040 
(.000**) 
1.196 L 
The answers range: 1 excellent (100)-poor (0), 2 definitely true (100)-definitely false (0); the lower the score, the worse quality of life; **p < 0.01 
Effect size, Cohen’s d: L, large. 
 
Pre- and post-transplant phase: psychological differ-
ences between cirrhotic patients on the waiting list 
and transplant recipients. 
 
With regard to affective status, statistically significant dif-
ferences were observed in the Anxiety (p ≤ .000) and De-
pression subscales (p ≤ .001, medium effect size). As ob-
served in Table 1 and Figure 2, waiting-list patients displayed 
higher levels of anxiety-depressive symptomatology in com-
parison to liver transplant recipients. Likewise, differences in 
the Anxiety subscale were very relevant (large effect size) and 
an item showed the greatest group differences (“I get a sort 
of frightened feeling as if something awful is about to 
happen”) (Table 3). 
Regarding quality of life, statistically significant differ-
ences were found in all SF-36 dimensions, except for Bodily 
Pain: Physical-Role (p ≤ .000), Mental Health (p = .005), 
General Health (p ≤ .000), Vitality (p ≤ .000), Social Func-
tioning (p = .011), Emotional-Role (p = .048), and Physical 
Functioning (p ≤ .000). Among these variables, the following 
had medium effect sizes: Mental Health, Social Functioning, 
and Vitality. And the remaining variables (except for Emo-
tional-Role) reached large effect sizes (Table 1). Particularly, 
in the Physical-Role dimension, the item which most empha-
sized group differences was, “How long have you had diffi-
culty performing work or other activities (for example, it 
took extra effort), as a result of your physical health?” (See 
Table 3). In the General Health dimension, there were very 
relevant differences in three items. And regarding the Physi-
cal Functioning dimension, two items showed the greatest 
differences. 
In all these dimensions, transplant patients reached high-
er scores than waiting-list patients. Therefore, the former 
showed better quality of life (Table 1 and Figure 1). 
Correlations between MELD scores and affective 
and quality of life dimensions as a function of type 
of phase 
 
Firstly, we compared scores on MELD scale among the 
three groups: pre-waiting-list cirrhotic patients (M1 = 15.81, 
SD = 4.139), waiting-list cirrhotic patients (M2 = 16.75, SD 
= 3.938), and transplant patients (M3 = 17.17, SD = 4.018). 
In view of fact there were missing values, we performed the-
se analyses by means of a different sample size: 48 cirrhotic 
patients and 42 transplant recipients. No statistically signifi-
cant differences were found in any comparison (t (47)1-2 = -
1.929, p = .060; t (88)1-3 = 1.570, p = .120; t (88)2-3 = .496, p 
= .621), and the magnitude of these differences was small 
(null and small effect sizes: d1-2 = -0.23; d1-3 = -0.33; d2-3 = -
0.11).  
Likewise, we computed Pearson’s correlations between 
MELD scores and affective and quality-of-life dimensions as 
a function of type of phase (pre-waiting-list study, waiting 
list, and transplant). No statistically significant correlations 
were found in any group, excepting for waiting-list patients 
between MELD and Anxiety subscale (r = .306, p = .029), 
and between MELD and SF-36 Social Functioning (r = -
.286, p = .042); the correlations were moderate and small-to-
moderate, respectively.  
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Table 3. Comparisons between liver transplant recipients and patients on waiting list regarding HADS and SF-36 dimensions with a large (L) effect size. 
Items Analysis. 
HADS ITEM 
Liver transplant 
recipients 
(n = 51) 
M (SD) 
Waiting list 
patients 
(n = 51) 
M (SD) 
t-test 
(p) 
Cohen’s 
d 
Anxiety     
- I get a sort of frightened feeling as if something awful is about to 
happen 1 
0.61 
(0.72) 
1.33 
(0.95) 
t(93.29) = -4.333 
(.000**) 
-0.854 L 
SF-36 ITEMS     
Physical-role 
During the past 4 weeks: 
    
- How long have you had difficulty performing the work or other ac-
tivities (for example, it took extra effort), as a result of your physical 
health? 2 
66.18 
(34.21) 
35.78 
(31.72) 
t(100) = 4.652 
(.000**) 
0.922 L 
 
General health 
- In general, would you say your health is… 3 
 
57.84 
(26.22) 
 
20.10 
(18.04) 
 
t(88.68) = 8.470 
(.000**) 
 
1.677 L 
 
How true or false is each of the following statements for you:   
 
 
 
- I am as healthy as anybody I know 4 60.78 
(32.88) 
25.49 (26.22) t(95.27) = 5.993 
(.000**) 
1.187 L 
- My health is excellent  4 
 
63.24 
(32.15) 
22.06 (25.81) 
 
t(95.53) = 7.132 
(.000**) 
1.413 L 
Physical functioning 
Does your current health limit you in...: 
- vigorous activities, such as running, lifting heavy objects, participat-
ing in strenuous sports? 5 
 
 
35.29 
(35.06) 
 
 
10.78 
(20.77) 
 
 
t(81.24) = 4.295 
(.000**) 
 
 
0.851 L 
- moderate activities, such as moving a table, pushing a vacuum clean-
er, bowling, or walking more than a hour? 5 
67.65 
(37.18) 
30.39 
(38.83) 
t(100) = 4.949 
(.000**) 
0.980 L 
The answers range: 1 Very definitely and quite badly (3)-Not at all (0), 2 always (0)-never (100), 3 excellent (100)-poor (0), 4 definitely true (100)-definitely false 
(0), 5 Yes, limited a lot (0)-No, not limited at all (100); the lower the score, the worse quality of life; **p < 0.01 
Effect sizes, Cohen’s d: L, large. 
 
Discussion 
 
In this study, we aimed to analyze the quality of life and af-
fective status among three liver patient groups, from the fol-
lowing comparisons: 1) cirrhotic patients in the pre-waiting-
list study with patients on the waiting list for a liver trans-
plant; 2) cirrhotic patients from the pre-waiting-list study and 
liver transplant recipients; 3) cirrhotic patients on the waiting 
list and liver transplant recipients. Lastly, we aimed to ana-
lyze the correlations between these quality of life and affec-
tive variables and MELD scores. 
Regarding the first goal, no relevant differences were 
found either in anxiety-depressive symptomatology or in 
quality of life between cirrhotic patients at the two assess-
ment phases: when they were in the pre-waiting-list study 
and on waiting list for transplant. Thus, although patients at 
the waiting-list phase displayed statistically significant higher 
impairment on the Physical-Role and General Health sub-
scales, these discrepancies were of a minimal magnitude 
(small effect sizes). In this sense, patients on the waiting list 
were slightly more impaired in their daily activities due to 
their physical condition, in comparison to those who were at 
a previous phase; the waiting-list patients also perceived 
themselves as slightly worse in terms of global health status.  
With regard to the second goal, transplant recipients en-
joyed better outcomes than pre-waiting-list patients, both in 
anxiety-depressive symptomatology (medium effect sizes) 
and quality of life, mainly in the physical dimensions. The 
differences obtained were of moderate magnitude (medium 
effect sizes) in the Physical Functioning, role limitations due 
to physical problems (Physical-Role), and Vitality subscales. 
On the one hand, to explain results in the affective area 
(anxiety-depressive symptomatology), we should take into 
account that cirrhotic patients in the pre-waiting-list study 
were hospitalized and had to undergo several medical tests 
that would decide their inclusion on the waiting list for sub-
sequent liver transplant. Hospitalization generates loss of 
control over one’s own life and involves several identified 
stressful factors, such as isolation, loss of intimacy, deper-
sonalization, interruption of daily roles, etc. Likewise, while 
they are hospitalized, the patients receive a large amount of 
information that must be assimilated, which -along with the 
uncertainty due to the results of the medical tests- can pro-
duce high levels of anxiety in view of the possibility of a liver 
transplant. On the other hand, quality of life was more im-
paired among the pre-waiting-list patients, because cirrhosis 
involves several medical complications, particularly related to 
the physical domain (fatigue, ascites, encephalopathy, vari-
ceal bleeding, etc.) (Díaz-Domínguez, Pérez-Bernal, Pérez-
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San-Gregorio, & Martín-Rodríguez, 2006; Molina-Jiménez, 
Gutiérrez-García, Hernández-Domínguez, & Contreras, 
2008). Consequently, both groups displayed very relevant 
differences (large effect size) in the General Health scale. 
Hence, the pre-waiting-list patients perceived their global 
health status as much worse than the liver transplant recipi-
ents. In this sense, it was highlighted that they were not as 
healthy as people they knew, and that their health was not 
excellent.   
Regarding the third goal, except for the Bodily Pain and 
the Emotional-Role dimensions, transplant patients enjoyed 
higher physical, psychological, and social well-being, in terms 
of statistical significance and of effect sizes (both large and 
medium ones) in all the remaining variables studied, in com-
parison to patients at the waiting-list stage. This negative af-
fective status and worse quality of life among cirrhotic pa-
tients may be attributed to the fact that they were at a phase 
that was full of uncertainty due to poor information about 
diagnosis, complex decisions about future transplant, igno-
rance about organ availability, unclear expectations about 
medical procedures and results, etc. Likewise, waiting-list pa-
tients experience feelings of loss of freedom because of hav-
ing to be localized 24 hours a day, as well as they suffer high 
levels of anxiety due to having to be admitted to an operat-
ing theater in order to undergo a high risk intervention 
(Brown, Sorrell, McClaren, & Creswel, 2006; Dudley, Chap-
lin, Clifford & Mutimer, 2007; Jurado et al., 2011; López-
Navas et al., 2011; Martin, Stone, Scott, & Brashers, 2010). In 
this same vein, the waiting-list patients of this investigation 
commented much more frequently than transplant recipients 
that they felt frightened, as if something awful was about to 
happen. However, although quality of life is better among 
transplant recipients, risk of rejection and side effects from 
immunosuppressive drugs are always present (Morales, Varo, 
& Lázaro, 2012; Sargent & Wainwright, 2006). On the other 
hand, impairment in the physical dimensions was much 
higher in waiting-list patients than in pre-waiting-list patients 
in comparison to liver transplant recipients; large effect sizes 
were obtained in the Physical Functioning and role limita-
tions due to physical problems (Physical-Role) scales. Thus, 
the waiting-list patients indicated that they had difficulty per-
forming their activities as a result of their physical health 
more frequently than the transplant recipients. They also suf-
fered more limitations performing vigorous activities (e.g., 
running, lifting heavy objects) or moderate activities (e.g., 
moving a table, pushing a vacuum cleaner, walking more 
than an hour). Therefore, the slightly higher impairment in 
the Physical-Role subscale in waiting-list patients in compari-
son to pre-waiting-list patients was more notable when com-
pared to transplant recipients.  
These differences cannot be attributed to hepatic disease 
severity as measured by MELD scores, because neither sta-
tistically significant group differences nor relevant effect siz-
es were found in this clinical scale, nor were statistically sig-
nificant correlations found between the SF-36 physical di-
mensions and MELD. Along the same line as other investi-
gation, MELD scores only were weakly correlated with the 
SF-36 physical subscales, or did not predict scores in SF-36 
dimensions (Saab et al., 2005). Therefore, as these and other 
authors conclude, physical quality of life impairment in pre-
transplant patients may be explained by hepatopathy indica-
tors such as ascites and encephalopathy (Les et al., 2010), 
which are not included in the MELD score. However, other 
authors (Rodrigue et al., 2006) state that these signs of de-
compensated cirrhosis do not predict post-transplantation 
quality of life.  
On the other hand, in view of this higher physical im-
pairment, waiting-list patients also perceived their global 
health status as much worse than transplant recipients, as 
was also the case with the pre-waiting-list patients. Likewise, 
they also commented they were not as healthy as people they 
knew, and their health was not excellent in comparison to 
the transplant recipients. 
Moreover, regarding the last goal, no statistically signifi-
cant correlations were found between quality of life, affective 
status, and MELD in any group, except for the waiting-list 
patients. In this group, not even significant weak correlations 
were found between SF-36 physical dimensions and MELD, 
as could be expected from other investigations about pa-
tients on the waiting list for liver transplant; although the 
correlation between MELD scores and mental health (meas-
ured by the HADS Anxiety subscale in our study) was cor-
roborated by a higher effect size (Saab et al., 2005). On the 
contrary, another statistically significant correlation found 
between MELD and the variables studied was in the SF-36 
Social Functioning dimension. Thus, this indicator of liver 
disease severity was weakly to moderately related to impair-
ment of daily social relationships (with friends, family and 
neighbors) among patients awaiting for liver transplant. This 
result was found in another investigation, although the 
hepatopathy severity measure was the pre-transplant Child-
Turcott-Pugh score, and social functioning was a post-
transplant outcome (Karam et al., 2003).  
In conclusion, waiting-list patients displayed the worst 
biopsychosocial health status, followed by pre-waiting-list 
patients and liver transplant recipients; the latter enjoyed the 
best quality of life and affective status (Ortiz & Alós, 2011). 
Moreover, the MELD score is not sufficient to explain the 
differences between these groups, because relevant contrasts 
regarding quality of life and affective domains were found 
between patients in pre-transplant phases and liver trans-
plant recipients, although the MELD scores were similar 
among them. Likewise, the MELD was only related to affec-
tive and social dimensions among the waiting-list patients 
and not to physical quality-of-life domains.  
Lastly, although our results confirm the benefits derived 
from liver transplant as the intervention of choice in order to 
improve severe cirrhotic patients’ quality of life and affective 
functioning, psychological treatments are also necessary dur-
ing the entire medical transplant protocol to achieve better 
biopsychosocial adjustment. On the one hand, particularly in 
the pre-transplant phase, because worse mental health pre-
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dicts negative post-transplant outcomes (Kelly et al., 2006; 
Zipfel et al., 2002). On the other hand, even in the post-
transplant phase, because these patients do not achieve the 
well-being levels of the general population (Estraviz et al., 
2007; Kousoulas et al., 2008) and mental health impairment 
predicts worse daily functioning -by means of fatigue- (Van 
Ginneken et al., 2010) and mortality after transplant (Pérez-
San-Gregorio, Martín-Rodríguez, Galán-Rodríguez, & Bor-
da-Más, 2009). Likewise, if the psychological complications 
at the pre-waiting-list-study phase are identified and treated, 
future disorders will be prevented in next stages such as at 
the waiting-list and post-transplant phases. 
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